| Literature DB >> 35106045 |
Owen Garrick1, Ruben Mesa2, Andrea Ferris3, Edward S Kim4, Edith Mitchell5, Otis W Brawley6, John Carpten7, Keith D Carter8, Joseph Coney9, Robert Winn10, Stephanie Monroe11, Fabian Sandoval12, Edith Perez13, Mitzi Williams14, Evan Grove15, Quita Highsmith16, Nicole Richie16, Susan M Begelman16, Asha S Collins16, Jamie Freedman16, Melissa S Gonzales16, Gerren Wilson16.
Abstract
Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-person committee dedicated to developing strategies to increase clinical research participation. To help improve the recruitment and retention of patients of color, this article chronicles our efforts to tangibly address the clinical research barriers at the system, study, and patient levels over the last four years. These efforts are one of the initial steps to fully realize the promise of personalized health care and provide increased patient benefit at less cost to society. Instead of simply acknowledging the problem, here we illuminate the collaborative and multilevel strategies that have been effective in delivering meaningful progress for patients.Entities:
Keywords: COVID-19; Clinical Trial Design; Health Care Disparities; Minority Health; Personalized Health Care
Year: 2022 PMID: 35106045 PMCID: PMC8785867 DOI: 10.18865/ed.32.1.61
Source DB: PubMed Journal: Ethn Dis ISSN: 1049-510X Impact factor: 2.006